Skip to main content
Premium Trial:

Request an Annual Quote

Amersham to Distribute Gene Logic s Products in Japan

NEW YORK, Sept 26 – Gene Logic (Nasdaq: GLGC) said Tuesday it had reached a deal that would give Amersham Pharmacia Biotech K.K. the exclusive rights to market sell Gene Logic’s products in Japan.

Under the terms of the deal, Amersham Pharmacia Biotech K.K, the Japanese subsidiary of Amersham Pharmacia Biotech, will market and sell Gene Logic’s range of databases and software tools to Japanese pharmaceutical and biotech companies.

Financial terms of the agreement were not disclosed.

“This alliance fits with Amersham Pharmacia Biotech K.K.'s business strategy and will help further strengthen our position in the genomics market in Japan," Kazuo Takeuchi, vice president at Amersham Pharmacia Biotech K.K., said in a statement.

Mark Gessler, president and CEO of Gene Logic, said the deal reflected the company’s efforts to expand its marketing reach overseas.

Amersham Pharmacia Biotech, is the life sciences division of Nycomed Amersham (London: NAM; NYSE: NYE).

Gene Logic, of Gaithersburg, Md., has developed a database that contains information about gene expression in human and animal tissues.

Shares of Gene Logic were down 3/4, or 3.6 percent, at 201/4 in afternoon trading.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.